References
- GorbachSLBismuth therapy in gastrointestinal diseasesGastroenterology19909938638752199292
- WagstaffAJBenfieldPMonkJPColloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer diseaseDrugs19883621321573053124
- CengizNUsluYGökFAnaratAAcute renal failure after overdose of colloidal bismuth subcitratePediatr Nephrol20052091355135815947979
- StevensPEMooreDFHouseIMVolansGNRainfordDJSignificant elimination of bismuth by haemodialysis with a new heavy-metal chelating agentNephrol Dial Transplant19951056966987566586
- VolansGNKarallieddeLWisemanHMReview of Succimer for Treatment of Lead Poisoning Geneva, SwitzerlandWorld Health Organization2010 Available from: http://www.who.int/selection_medicines/committees/expert/18/applications/succimer.pdfAccessed October 15, 2013
- SlikkerveerANoachLATytgatGNVan der VoetGBDe WolffFAComparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acidAnalyst1998123191929581027
- LeussinkBTSlikkerveerAEngelbrechtMRWColloidal bismuth subcitrate-induced nephrotoxicity: reversibility and morphology (abstract). Proceedings of the Dutch Society of Nephrology 59th Scientific Meeting; January 17, 1998; Leiden The NetherlandsKidney Int19995531170
- LeussinkBTSlikkerveerAKrauwinkelWJBismuth biokinetics and kidney histopathology after bismuth overdose in ratsArch Toxicol200074734935511043489
- Loghman-AdhamMAminoaciduria and glycosuria following severe childhood lead poisoningPediatr Nephrol19981232182219630041
- TürkezHGeyikoğluFKeleşMSBiochemical response to colloidal bismuth subcitrate: dose-time effectBiol Trace Elem Res20051051–315115816034160
- SujathaRJayakumarARKrishnamoorthyMSPaulVJayakumarRBehavioural and biochemical changes after simultaneous and post-treatment of vitamin A and D on cadmium toxicityEnviron Toxicol Pharmacol19997318919721781925